International Immunology, Vol 9, 1875-1883, Copyright © 1997 by Oxford University Press
FA Bonilla, CM Kokron, P Swinton and RS Geha
CD7 is a 40 kDa type I transmembrane glycoprotein member of the Ig
superfamily. CD7 is a marker of mature human T cells and NK cells, and is
expressed early in their development. Cross-linking CD7 positively
modulates T cell and NK cell activity as measured by calcium fluxes,
expression of adhesion molecules, cytokine secretion and proliferation. CD7
associates directly with phosphoinositol 3'-kinase, and CD7 ligation
induces production of D-3 phosphoinositides and tyrosine phosphorylation.
Severe combined immunodeficiency has been associated with a lack of
lymphocyte surface CD7. The CD7 ligand is unknown. The murine CD7 homolog
is encoded by a single gene on chromosome 11. In order to characterize the
role of CD7 in lymphocyte development and function we have eliminated the
CD7 gene by targeted disruption. CD7- deficient mice display normal
histology of thymus and spleen, normal lymphocyte populations in primary
and secondary lymphoid tissues, and normal serum Ig levels. Specific
antibody responses after immunization with T-dependent and T-independent
antigens are equivalent in wild-type and CD7 knockout mice. CD7-deficient
lymphocytes respond normally to T cell mitogenic and allogeneic stimuli,
and display normal NK cell cytotoxicity.
ARTICLES
Targeted gene disruption of murine CD7
Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. De Smedt, I. Hoebeke, K. Reynvoet, G. Leclercq, and J. Plum Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironment Blood, November 15, 2005; 106(10): 3498 - 3506. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Ferrando, S. A. Armstrong, D. S. Neuberg, S. E. Sallan, L. B. Silverman, S. J. Korsmeyer, and A. T. Look Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation Blood, July 1, 2003; 102(1): 262 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Heinly, G. D. Sempowski, D. M. Lee, D. D. Patel, P. M. McDermott, R. M. Scearce, C. B. Thompson, and B. F. Haynes Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice Int. Immunol., February 1, 2001; 13(2): 157 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Pace, H. P. Hahn, M. Pang, J. T. Nguyen, and L. G. Baum Cutting Edge: CD7 Delivers a Pro-Apoptotic Signal During Galectin-1-Induced T Cell Death J. Immunol., September 1, 2000; 165(5): 2331 - 2334. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Lyman, S. Escobar, A.-M. Rousseau, A. Armstrong, and W. C. Fanslow Identification of CD7 as a Cognate of the Human K12 (SECTM1) Protein J. Biol. Chem., February 4, 2000; 275(5): 3431 - 3437. [Abstract] [Full Text] [PDF] |
||||



